CHC (CCB): The Overlapping-Use Hotline Call

No. Waiting for corroboration conflicts with the standard that credible allegations of potential fraud be assessed promptly, regardless of the subject's revenue or board status. The CO should apply a risk-based triage: (1) Severity - concurrent OR scheduling with duplicate billing implicates federal health care program billing and potentially the False Claims Act; high severity. (2) Credibility - a unit-level nurse with direct observation is a plausible, specific source, not a vague rumor. (3) Exposure/scale - recurring pattern across an unknown number of cases; potentially material. (4) Retaliation/whistleblower risk - delaying on a high-revenue, board-connected physician creates a retaliation and culture risk if the reporter is later identified.

The manager's 'wait and see' is not a legitimate triage outcome; it is deferral driven by the subject's status. The CO should document the intake, open a preliminary inquiry (not a full investigation yet), and set a defined scope and timeline. Board membership and revenue are conflicts to be managed (e.g., recusal, escalation to the audit committee), not reasons to slow down. The CO should also confirm the hotline's anti-retaliation notice was given and preserve the anonymous reporter's confidentiality.

A defensible 10-day plan:

1. Intake documentation - record the call verbatim, date/time, reporter's stated role, and the specific allegation (concurrent OR scheduling + duplicate billing). Assign a case number and confidentiality classification.
2. Conflict check and escalation - because the subject is a board quality-committee member, notify the audit committee chair (or general counsel if the CO reports through legal) and document the conflict. Do not notify the subject or the manager who suggested delay.
3. Preliminary data pull - request, through a controlled channel, OR scheduling logs and claims data for the physician for a defined look-back (e.g., 12 months) to test whether overlapping cases exist and whether both were billed. Keep the request narrow and need-to-know.
4. No-contact preservation - instruct IT/HR to preserve relevant records; do not tip off the surgical unit.
5. Scope memo - define what is being tested (scheduling overlap vs. billing duplication vs. medical necessity), the time period, and the decision points for escalation to a full investigation.
6. Reporter protection - confirm anti-retaliation language was communicated and that no one has attempted to identify the caller.

Document each step with dates and owners so the file shows prompt, risk-based action.

The finding is mixed and must be characterized precisely rather than as 'fraud confirmed' or 'no problem.'

• 14 overlaps establish a scheduling-control weakness: the OR scheduling system permits one surgeon in two rooms concurrently, which may be clinically appropriate (e.g., staggered start with a qualified assistant) or not. This is a process/internal-control finding.
• 3 duplicate billings are the higher-risk subset: these are potential overpayments and must be quantified, disclosed/refunded per the organization's overpayment policy and applicable 60-day repayment rules, and reviewed for whether the pattern is intentional.

The CO should not close the case on the 3 billings alone; the 11 non-billed overlaps still need a clinical/operational review to determine whether the physician was present and directing care as required. The characterization drives next steps: (a) open a focused billing review and overpayment quantification, (b) refer the scheduling-control gap to the OR/medical staff leadership for a control fix, and (c) decide whether the 3 billings warrant a full investigation (intent, pattern, prior years). Document the reasoning so the file shows why the case was bifurcated into a billing issue and a control issue.